InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Palmer Ashleigh, Chairman & CEO. Director active across 1 company, notably Provention Bio, Inc.. Cumulatively, 2 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €44k. History available since 30 November 2021. The latest transaction was disclosed on 30 November 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
3,750 shares@ US$6.664100.0% of flowCommon StockSEC:0001493152-21-030245
Ideal exit: 27 Aug 2022 (T+270)
3,750 shares@ US$6.66450.0% of flowCommon StockSEC:0001493152-21-030245:0
Ideal exit: 27 Aug 2022 (T+270)
2 of 2 declarations
About Palmer Ashleigh
Ashleigh Palmer is the Director and CEO of Provention Bio, Inc. She leads the company by defining its strategic vision and overseeing its operations. Her expertise in the biopharmaceutical field enables her to guide Provention Bio towards cutting-edge innovations and therapeutic solutions.
